Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 211
Filtrer
1.
Biol Res ; 57(1): 10, 2024 Mar 17.
Article de Anglais | MEDLINE | ID: mdl-38494498

RÉSUMÉ

BACKGROUND: The senescence of renal tubular epithelial cells (RTECs) is crucial in the progression of diabetic kidney disease (DKD). Accumulating evidence suggests a close association between insufficient mitophagy and RTEC senescence. Yeast mitochondrial escape 1-like 1 (YME1L), an inner mitochondrial membrane metalloprotease, maintains mitochondrial integrity. Its functions in DKD remain unclear. Here, we investigated whether YME1L can prevent the progression of DKD by regulating mitophagy and cellular senescence. METHODS: We analyzed YME1L expression in renal tubules of DKD patients and mice, explored transcriptomic changes associated with YME1L overexpression in RTECs, and assessed its impact on RTEC senescence and renal dysfunction using an HFD/STZ-induced DKD mouse model. Tubule-specific overexpression of YME1L was achieved through the use of recombinant adeno-associated virus 2/9 (rAAV 2/9). We conducted both in vivo and in vitro experiments to evaluate the effects of YME1L overexpression on mitophagy and mitochondrial function. Furthermore, we performed LC-MS/MS analysis to identify potential protein interactions involving YME1L and elucidate the underlying mechanisms. RESULTS: Our findings revealed a significant decrease in YME1L expression in the renal tubules of DKD patients and mice. However, tubule-specific overexpression of YME1L significantly alleviated RTEC senescence and renal dysfunction in the HFD/STZ-induced DKD mouse model. Moreover, YME1L overexpression exhibited positive effects on enhancing mitophagy and improving mitochondrial function both in vivo and in vitro. Mechanistically, our LC-MS/MS analysis uncovered a crucial mitophagy receptor, BCL2-like 13 (BCL2L13), as an interacting partner of YME1L. Furthermore, YME1L was found to promote the phosphorylation of BCL2L13, highlighting its role in regulating mitophagy. CONCLUSIONS: This study provides compelling evidence that YME1L plays a critical role in protecting RTECs from cellular senescence and impeding the progression of DKD. Overexpression of YME1L demonstrated significant therapeutic potential by ameliorating both RTEC senescence and renal dysfunction in the DKD mice. Moreover, our findings indicate that YME1L enhances mitophagy and improves mitochondrial function, potentially through its interaction with BCL2L13 and subsequent phosphorylation. These novel insights into the protective mechanisms of YME1L offer a promising strategy for developing therapies targeting DKD.


Sujet(s)
Diabète , Néphropathies diabétiques , Humains , Souris , Animaux , Mitophagie/physiologie , Saccharomyces cerevisiae , Chromatographie en phase liquide , Spectrométrie de masse en tandem , Cellules épithéliales/métabolisme , Modèles animaux de maladie humaine , Vieillissement de la cellule , Diabète/métabolisme , Metalloendopeptidases/métabolisme , Metalloendopeptidases/pharmacologie
2.
Cell Rep ; 42(4): 112332, 2023 04 25.
Article de Anglais | MEDLINE | ID: mdl-37002921

RÉSUMÉ

The metabolic plasticity of mitochondria ensures cell development, differentiation, and survival. The peptidase OMA1 regulates mitochondrial morphology via OPA1 and stress signaling via DELE1 and orchestrates tumorigenesis and cell survival in a cell- and tissue-specific manner. Here, we use unbiased systems-based approaches to show that OMA1-dependent cell survival depends on metabolic cues. A metabolism-focused CRISPR screen combined with an integrated analysis of human gene expression data found that OMA1 protects against DNA damage. Nucleotide deficiencies induced by chemotherapeutic agents promote p53-dependent apoptosis of cells lacking OMA1. The protective effect of OMA1 does not depend on OMA1 activation or OMA1-mediated OPA1 and DELE1 processing. OMA1-deficient cells show reduced glycolysis and accumulate oxidative phosphorylation (OXPHOS) proteins upon DNA damage. OXPHOS inhibition restores glycolysis and confers resistance against DNA damage. Thus, OMA1 dictates the balance between cell death and survival through the control of glucose metabolism, shedding light on its role in cancerogenesis.


Sujet(s)
Metalloendopeptidases , Peptide hydrolases , Humains , ADN/métabolisme , dGTPases/métabolisme , Metalloendopeptidases/métabolisme , Mitochondries/métabolisme , Protéines mitochondriales/génétique , Protéines mitochondriales/métabolisme , Phosphorylation oxydative , Peptide hydrolases/métabolisme
3.
Biochim Biophys Acta Mol Basis Dis ; 1868(12): 166551, 2022 12 01.
Article de Anglais | MEDLINE | ID: mdl-36116726

RÉSUMÉ

The Spike glycoprotein of SARS-CoV-2, the virus responsible for coronavirus disease 2019, binds to its ACE2 receptor for internalization in the host cells. Elderly individuals or those with subjacent disorders, such as obesity and diabetes, are more susceptible to COVID-19 severity. Additionally, several SARS-CoV-2 variants appear to enhance the Spike-ACE2 interaction, which increases transmissibility and death. Considering that the fruit fly is a robust animal model in metabolic research and has two ACE2 orthologs, Ance and Acer, in this work, we studied the effects of two hypercaloric diets (HFD and HSD) and aging on ACE2 orthologs mRNA expression levels in Drosophila melanogaster. To complement our work, we analyzed the predicted binding affinity between the Spike protein with Ance and Acer. We show for the first time that Ance and Acer genes are differentially regulated and dependent on diet and age in adult flies. At the molecular level, Ance and Acer proteins exhibit the potential to bind to the Spike protein in different regions, as shown by a molecular docking approach. Acer, in particular, interacts with the Spike protein in the same region as in humans. Overall, we suggest that the D. melanogaster is a promising animal model for translational studies on COVID-19 associated risk factors and ACE2.


Sujet(s)
Angiotensin-converting enzyme 2 , COVID-19 , Diabète , Drosophila melanogaster , Obésité , Vieillissement/génétique , Angiotensin-converting enzyme 2/génétique , Animaux , COVID-19/génétique , Diabète/génétique , Protéines de Drosophila/génétique , Drosophila melanogaster/génétique , Drosophila melanogaster/métabolisme , Humains , Metalloendopeptidases/métabolisme , Simulation de docking moléculaire , Obésité/génétique , ARN messager , SARS-CoV-2 , Glycoprotéine de spicule des coronavirus/composition chimique
4.
Int J Mol Sci ; 23(15)2022 Aug 02.
Article de Anglais | MEDLINE | ID: mdl-35955687

RÉSUMÉ

Leishmanolysin, also known as major promastigote protease (PSP) or gp63, is the most abundant surface glycoprotein of Leishmania spp., and has been extensively studied and recognized as the main parasite virulence factor. Characterized as a metalloprotease, gp63 can be powerfully inactivated in the presence of a metal chelator. In this study, we first used the structural parameters of a 7-hydroxycoumarin derivative, L1 compound, to evaluate the theoretical-computational experiments against gp63, comparing it with an available metal chelator already described. The methodology followed was (i) analysis of the three-dimensional structure of gp63 as well as its active site, and searching the literature and molecular databases for possible inhibitors; (ii) molecular docking simulations and investigation of the interactions in the generated protein-ligand complexes; and (iii) the individual energy of the gp63 amino acids that interacted most with the ligands of interest was quantified by ab initio calculations using Molecular Fraction with Conjugated Caps (MFCC). MFCC still allowed the final quantum balance calculations of the protein interaction to be obtained with each inhibitor candidate binder. L1 obtained the best energy quantum balance result with -2 eV, followed by DETC (-1.4 eV), doxycycline (-1.3 eV), and 4-terpineol (-0.6 eV), and showed evidence of covalent binding in the enzyme active site. In vitro experiments confirmed L1 as highly effective against L. amazonensis parasites. The compound also exhibited a low cytotoxicity profile against mammalian RAW and 3T3 cells lines, presenting a selective index of 149.19 and 380.64 µM, respectively. L1 induced promastigote forms' death by necrosis and the ultrastructural analysis revealed disruption in membrane integrity. Furthermore, leakage of the contents and destruction of the parasite were confirmed by Spectroscopy Dispersion analysis. These results together suggested L1 has a potential effect against L. amazonensis, the etiologic agent of diffuse leishmaniasis, and the only one that currently does not have a satisfactory treatment.


Sujet(s)
Leishmania , Animaux , Chélateurs , Leishmania/métabolisme , Mammifères/métabolisme , Metalloendopeptidases/métabolisme , Metalloproteases , Souris , Simulation de docking moléculaire , Phagocytose
5.
Toxins (Basel) ; 14(7)2022 07 09.
Article de Anglais | MEDLINE | ID: mdl-35878210

RÉSUMÉ

Small RNAs (sRNAs) and microRNAs (miRNAs) are small endogenous noncoding single-stranded RNAs that regulate gene expression in eukaryotes. Experiments in mice and humans have revealed that a typical small RNA can affect the expression of a wide range of genes, implying that small RNAs function as global regulators. Here, we used small RNA deep sequencing to investigate how jararhagin, a metalloproteinase toxin produced from the venom of Bothrops jararaca, affected mmu-miRNAs expression in mice 2 hours (Jar 2hrs) and 24 hours (Jar 24hrs) after injection compared to PBS control. The findings revealed that seven mmu-miRNAs were substantially differentially expressed (p value (p (Corr) cut-off 0.05, fold change ≥ 2) at 2 hrs after jararhagin exposure and that the majority of them were upregulated when compared to PBS. In contrast to these findings, a comparison of Jar 24hrs vs. PBS 24hrs demonstrated that the majority of identified mmu-miRNAs were downregulated. Furthermore, the studies demonstrated that mmu-miRNAs can target the expression of several genes involved in the MAPK signaling pathway. The steady antithetical regulation of mmu-miRNAs may correlate with the expression of genes that trigger apoptosis via MAPK in the early stages, and this effect intensifies with time. The findings expand our understanding of the effects of jararhagin on local tissue lesions at the molecular level.


Sujet(s)
Bothrops , Venins de crotalidé , microARN , Animaux , Bothrops/métabolisme , Venins de crotalidé/métabolisme , Humains , Metalloendopeptidases/métabolisme , Metalloproteases/métabolisme , Souris , microARN/génétique , microARN/métabolisme , Muscles squelettiques/métabolisme , 60561
6.
Int J Mol Sci ; 23(14)2022 Jul 11.
Article de Anglais | MEDLINE | ID: mdl-35887004

RÉSUMÉ

Leishmania tarentolae is a non-pathogenic trypanosomatid isolated from lizards widely used for heterologous protein expression and extensively studied to understand the pathogenic mechanisms of leishmaniasis. The repertoire of leishmanolysin genes was reported to be expanded in L. tarentolae genome, but no proteolytic activity was detected. Here, we analyzed L. tarentolae leishmanolysin proteins from the genome to the structural levels and evaluated the enzymatic activity of the wild-type and overexpressing mutants of leishmanolysin. A total of 61 leishmanolysin sequences were retrieved from the L. tarentolae genome. Five of them were selected for phylogenetic analysis, and for three of them, we built 3D models based on the crystallographic structure of L. major ortholog. Molecular dynamics simulations of these models disclosed a less negative electrostatic potential compared to the template. Subsequently, L. major LmjF.10.0460 and L. tarentolae LtaP10.0650 leishmanolysins were cloned in a pLEXSY expression system into L. tarentolae. Proteins from the wild-type and the overexpressing parasites were submitted to enzymatic analysis. Our results revealed that L. tarentolae leishmanolysins harbor a weak enzymatic activity about three times less abundant than L. major leishmanolysin. Our findings strongly suggest that the less negative electrostatic potential of L. tarentolae leishmanolysin can be the reason for the reduced proteolytic activity detected in this parasite.


Sujet(s)
Leishmania , Leishmaniose , Parasites , Animaux , Leishmania/génétique , Leishmania/métabolisme , Leishmaniose/parasitologie , Metalloendopeptidases/métabolisme , Phylogenèse
7.
Chest ; 160(5): 1624-1633, 2021 11.
Article de Anglais | MEDLINE | ID: mdl-33878342

RÉSUMÉ

BACKGROUND: Pseudomonas aeruginosa (PA) is a common cause of respiratory infection and morbidity. Pseudomonas elastase is an important virulence factor regulated by the lasR gene. Whether PA elastase activity is associated with worse clinical outcomes in ICU patients is unknown. RESEARCH QUESTION: Is there an association between PA elastase activity and worse host outcomes in a cohort of ICU patients? METHODS: PA respiratory isolates from 238 unique ICU patients from two tertiary-care centers within the University of Pittsburgh Medical Center health system were prospectively collected and screened for total protease and elastase activity, biofilm production, antimicrobial resistance, and polymicrobial status. The association between pathogen characteristics and 30-day and 90-day mortality was calculated using logistic regression. For subgroup analysis, two patterns of early (≤72 h) and late sample (>72 h) collection from the index ICU admission were distinguished using a finite mixture model. Lung inflammation and injury was evaluated in a mouse model using a PA high elastase vs low elastase producer. RESULTS: PA elastase activity was common in ICU respiratory isolates representing 75% of samples and was associated with increased 30-day mortality (adjusted OR [95% CI]: 1.39 [1.05-1.83]). Subgroup analysis demonstrated that elastase activity was a risk factor for 30- and 90-day mortality in the early sample group, whereas antimicrobial resistance was a risk factor for 90-day mortality in the late sample group. Whole genome sequencing of high and low elastase producers showed that predicted loss-of-function lasR genotypes were less common among high elastase producers. Mice infected with a high elastase producer showed increased lung bacterial burden and inflammatory profile compared with mice infected with a low elastase producer. INTERPRETATION: Elastase activity is associated with 30-day ICU mortality. A high elastase producing clinical isolate confers increased lung tissue inflammation compared with a low elastase producer in vivo.


Sujet(s)
Protéines bactériennes/métabolisme , Maladie grave , Unités de soins intensifs/statistiques et données numériques , Poumon , Metalloendopeptidases/métabolisme , Mortalité , Pneumopathie bactérienne , Infections à Pseudomonas , Pseudomonas aeruginosa , Animaux , Corrélation de données , Maladie grave/mortalité , Maladie grave/thérapie , Démographie , Modèles animaux de maladie humaine , Femelle , Humains , Poumon/immunologie , Poumon/microbiologie , Mâle , Souris , Adulte d'âge moyen , Pneumopathie bactérienne/microbiologie , Pneumopathie bactérienne/mortalité , Infections à Pseudomonas/étiologie , Infections à Pseudomonas/mortalité , Pseudomonas aeruginosa/enzymologie , Pseudomonas aeruginosa/isolement et purification , Pseudomonas aeruginosa/pathogénicité , Ventilation artificielle/statistiques et données numériques , États-Unis/épidémiologie , Facteurs de virulence
8.
Scand J Immunol ; 93(1): e12962, 2021 Jan.
Article de Anglais | MEDLINE | ID: mdl-32853407

RÉSUMÉ

It has been reported that EMMPRIN is involved in the regulation of immune response and the induction of MMPs production by fibroblasts. The aim of this study was to describe the intestinal gene expression and protein production of EMMPRIN, MMP23 and MMP10 in patients with ulcerative colitis (UC) and Crohn's disease (CD) and compared them with a control group. Gene expression of EMMPRIN, MMP10 and MMP23B was measured by RT-PCR. In order to determine EMMPRIN and MMP protein expression, colonic tissues were immunostained. The results of the study showed EMMPRIN gene expression was upregulated in rectal mucosa from active (a)UC versus aCD patients (P = .045), remission (r)CD group (P = .0009) and controls (P < .0001). We detected differences between rUC and aCD (P = .004), rCD (P < .0001) or control group (P < .0001). EMMPRIN showed a higher expression in mucosa (intraepithelial lymphocytes), submucosa and adventitia (endothelial cells) from aCD patients. MMP23 levels were increased in aUC and aCD compared to rUC and rCD and the control group (P = .0001). EMMPRIN+/MMP23+─expressing cells were localized mainly in mucosa, muscular and adventitia from active UC patients. MMP10 gene expression was increased in aUC versus CD patients and the control group (P = .0001). MMP10 gene expression is associated with inflammation in UC patients (P = .0001, r2  = .585). EMMPRIN+/MMP10+─producing cells were found mainly in all intestinal layers and perivascular inflammatory infiltrates from aUC patients. In conclusion, EMMPRIN, MMP23 and MMP10 were upregulated in patients with active UC versus remission UC , CD and control groups suggesting that, they are involved in the inflammatory process.


Sujet(s)
Antigènes CD147/génétique , Expression des gènes , Maladies inflammatoires intestinales/génétique , Matrix metalloproteinase 10/génétique , Metalloendopeptidases/génétique , Adulte , Sujet âgé , Antigènes CD147/métabolisme , Marqueurs biologiques , Biopsie , Études cas-témoins , Études transversales , Prédisposition aux maladies , Femelle , Analyse de profil d'expression de gènes , Humains , Immunohistochimie , Maladies inflammatoires intestinales/métabolisme , Maladies inflammatoires intestinales/anatomopathologie , Maladies inflammatoires intestinales/thérapie , Mâle , Matrix metalloproteinase 10/métabolisme , Metalloendopeptidases/métabolisme , Adulte d'âge moyen , Liaison aux protéines
9.
Biomolecules ; 10(9)2020 08 24.
Article de Anglais | MEDLINE | ID: mdl-32847123

RÉSUMÉ

Thimet oligopeptidase (EC 3.4.24.15; EP24.15, THOP1) is a metallopeptidase ubiquitously distributed in mammalian tissues. Beyond its previously well characterized role in major histocompatibility class I (MHC-I) antigen presentation, the recent characterization of the THOP1 C57BL6/N null mice (THOP1-/-) phenotype suggests new key functions for THOP1 in hyperlipidic diet-induced obesity, insulin resistance and non-alcoholic liver steatosis. Distinctive levels of specific intracellular peptides (InPeps), genes and microRNAs were observed when comparing wild type C57BL6/N to THOP1-/- fed either standard or hyperlipidic diets. A possible novel mechanism of action was suggested for InPeps processed by THOP1, which could be modulating protein-protein interactions and microRNA processing, thus affecting the phenotype. Together, research into the biochemical and biomedical significance of THOP1 suggests that degradation by the proteasome is a step in the processing of various proteins, not merely for ending their existence. This allows many functional peptides to be generated by proteasomal degradation in order to, for example, control mRNA translation and the formation of protein complexes.


Sujet(s)
Metalloendopeptidases/composition chimique , Metalloendopeptidases/métabolisme , Séquence d'acides aminés , Animaux , Présentation d'antigène , Domaine catalytique , Encéphalomyélite auto-immune expérimentale/enzymologie , Encéphalomyélite auto-immune expérimentale/génétique , Encéphalomyélite auto-immune expérimentale/immunologie , Métabolisme énergétique , Femelle , Études d'associations génétiques , Antigènes d'histocompatibilité de classe I/métabolisme , Humains , Mâle , Metalloendopeptidases/génétique , Souris , Souris de lignée C57BL , Souris knockout , Modèles biologiques , Neuropeptides/métabolisme , Inhibiteurs de protéases/pharmacologie , Proteasome endopeptidase complex/métabolisme , Protéolyse , Spécificité du substrat
10.
J Gerontol A Biol Sci Med Sci ; 75(12): 2258-2261, 2020 11 13.
Article de Anglais | MEDLINE | ID: mdl-32173728

RÉSUMÉ

The impairment of the mitochondrial functions is a hallmark of aging. During aging, there is a downregulation of two mechanisms strictly associated with mitochondrial integrity, including the mitonuclear imbalance (eg, imbalance in mitochondrial- versus nuclear-encoded mitochondrial proteins) and the mitochondrial unfolded protein response (UPRmt). Here, we evaluated the effects of aerobic exercise in the mitonuclear imbalance and UPRmt markers in the skeletal muscle of old mice. We combined the physiological tests, molecular and bioinformatic analyzes to evaluate the effects of 4 weeks of aerobic exercise training on mitonuclear imbalance and UPRmt markers in the skeletal muscle of young (2 months) and aged (24 months) C57BL/6J mice. Initially, we found that aging reduced several mitochondrial genes in the gastrocnemius muscle, and it was accompanied by the low levels of UPRmt markers, including Yme1l1 and Clpp mRNA. As expected, physical training improved the whole-body metabolism and physical performance of aged mice. The aerobic exercise increased key proteins involved in the mitochondrial biogenesis/functions (VDAC and SIRT1) along with mitochondrial-encoded genes (mtNd1, mtCytB, and mtD-Loop) in the skeletal muscle of old mice. Interestingly, aerobic exercise induced the mitonuclear imbalance, increasing MTCO1/ATP5a ratio and UPRmt markers in the skeletal muscle, including HSP60, Lonp1, and Yme1L1 protein levels in the gastrocnemius muscle of aged mice. These data demonstrate that aerobic exercise training induced mitonuclear imbalance and UPRmt in the skeletal muscle during aging. These phenomena could be involved in the improvement of the mitochondrial metabolism and oxidative capacity in aged individuals.


Sujet(s)
Vieillissement/physiologie , Mitochondries du muscle/métabolisme , Muscles squelettiques/métabolisme , Conditionnement physique d'animal/physiologie , Réponse aux protéines mal repliées/physiologie , Animaux , Endopeptidase Clp/métabolisme , Mâle , Metalloendopeptidases/métabolisme , Souris , Souris de lignée C57BL , Sirtuine-1/métabolisme , Canal anionique-1 voltage-dépendant/métabolisme
11.
Biomolecules ; 10(2)2020 02 17.
Article de Anglais | MEDLINE | ID: mdl-32079362

RÉSUMÉ

Thimet oligopeptidase (EC 3.4.24.15; EP24.15; THOP1) is a potential therapeutic target, as it plays key biological functions in processing biologically functional peptides. The structural conformation of THOP1 provides a unique restriction regarding substrate size, in that it only hydrolyzes peptides (optimally, those ranging from eight to 12 amino acids) and not proteins. The proteasome activity of hydrolyzing proteins releases a large number of intracellular peptides, providing THOP1 substrates within cells. The present study aimed to investigate the possible function of THOP1 in the development of diet-induced obesity (DIO) and insulin resistance by utilizing a murine model of hyperlipidic DIO with both C57BL6 wild-type (WT) and THOP1 null (THOP1-/-) mice. After 24 weeks of being fed a hyperlipidic diet (HD), THOP1-/- and WT mice ingested similar chow and calories; however, the THOP1-/- mice gained 75% less body weight and showed neither insulin resistance nor non-alcoholic fatty liver steatosis when compared to WT mice. THOP1-/- mice had increased adrenergic-stimulated adipose tissue lipolysis as well as a balanced level of expression of genes and microRNAs associated with energy metabolism, adipogenesis, or inflammation. Altogether, these differences converge to a healthy phenotype of THOP1-/- fed a HD. The molecular mechanism that links THOP1 to energy metabolism is suggested herein to involve intracellular peptides, of which the relative levels were identified to change in the adipose tissue of WT and THOP1-/- mice. Intracellular peptides were observed by molecular modeling to interact with both pre-miR-143 and pre-miR-222, suggesting a possible novel regulatory mechanism for gene expression. Therefore, we successfully demonstrated the previously unanticipated relevance of THOP1 in energy metabolism regulation. It was suggested that intracellular peptides were responsible for mediating the phenotypic differences that are described herein by a yet unknown mechanism of action.


Sujet(s)
Métabolisme énergétique , Metalloendopeptidases/métabolisme , Obésité/métabolisme , Adipogenèse , Tissu adipeux/métabolisme , Animaux , Alimentation riche en graisse/effets indésirables , Femelle , Délétion de gène , Insulinorésistance , Lipolyse , Mâle , Metalloendopeptidases/génétique , Souris , Souris de lignée C57BL , Obésité/étiologie , Obésité/génétique
12.
Biochem Biophys Res Commun ; 522(2): 368-373, 2020 02 05.
Article de Anglais | MEDLINE | ID: mdl-31761323

RÉSUMÉ

Thimet oligopeptidase (TOP, EC 3.4.24.15) and neurolysin (NEL, EC 3.4.24.16) are closely related zinc-dependent metalo-oligopeptidases, which take part in the metabolism of oligopeptides (from 5 to 17 amino acid residues) inside and outside cells. Both peptidases are ubiquitously distributed in tissues. TOP is one of the main intracellular peptide-processing enzymes being important for the antigen selection in the MHC Class I presentation route, while NEL function has been more associated with the extracellular degradation of neurotensin. Despite efforts being made to develop specific inhibitors for these peptidases, the most used are: CPP-Ala-Ala-Tyr-PABA, described by Orlowski et al. in 1988, and CPP-Ala-Aib-Tyr-PABA (JA-2) that is an analog more resistant to proteolysis, which development was made by Shrimpton et al. in 2000. In the present work, we describe other analogs of these compounds but, with better discriminatory capacity to inhibit specifically NEL or TOP. The modifications introduced in these new analogs were based on a key difference existent in the extended binding sites of NEL and TOP: the negatively charged Glu469 residue of TOP corresponds to the positively charged Arg470 residue of NEL. These residues are in position to interact with the residue at the P1' and/or P2' of their substrates (mimicked by the Ala-Ala/P1'-P2' residues of the CPP-Ala-Ala-Tyr-PABA). Therefore, exploring this single difference, the following compounds were synthesized: CPP-Asp-Ala-Tyr-PABA, CPP-Arg-Ala-Tyr-PABA, CPP-Ala-Asp-Tyr-PABA, CPP-Ala-Arg-Tyr-PABA. Confirming the predictions, the replacement of each non-charged residue of the internal portion Ala-Ala by a charged residue Asp or Arg resulted in compounds with higher selectivity for NEL or TOP, especially due to the electrostatic attraction or repulsion by the NEL Arg470 or TOP Glu469 residue. The CPP-Asp-Ala-Tyr-PABA and CPP-Ala-Asp-Tyr-PABA presented higher affinities for NEL, and, the CFP-Ala-Arg-Tyr-PABA showed higher affinity for TOP.


Sujet(s)
Metalloendopeptidases/métabolisme , Oligopeptides/pharmacologie , Cinétique , Metalloendopeptidases/antagonistes et inhibiteurs , Mutation/génétique , Oligopeptides/synthèse chimique , Oligopeptides/composition chimique , Spécificité du substrat/effets des médicaments et des substances chimiques
13.
Article de Anglais | MEDLINE | ID: mdl-31555609

RÉSUMÉ

Leishmania (Viannia) braziliensis is responsible for the largest number of American tegumentary leishmaniasis (ATL) in Brazil. ATL can present several clinical forms including typical (TL) and atypical (AL) cutaneous and mucocutaneous (ML) lesions. To identify parasite and host factors potentially associated with these diverse clinical manifestations, we first surveyed the expression of two virulence-associated glycoconjugates, lipophosphoglycan (LPG) and the metalloprotease GP63 by a panel of promastigotes of Leishmania braziliensis (L. braziliensis) strains isolated from patients with different clinical manifestations of ATL and from the sand fly vector. We observed a diversity of expression patterns for both LPG and GP63, which may be related to strain-specific polymorphisms. Interestingly, we noted that GP63 activity varies from strain to strain, including the ability to cleave host cell molecules. We next evaluated the ability of promastigotes from these L. braziliensis strains to modulate phagolysosome biogenesis in bone marrow-derived macrophages (BMM), by assessing phagosomal recruitment of the lysosome-associated membrane protein 1 (LAMP-1) and intraphagosomal acidification. Whereas, three out of six L. braziliensis strains impaired the phagosomal recruitment of LAMP-1, only the ML strain inhibited phagosome acidification to the same extent as the L. donovani strain that was used as a positive control. While decreased phagosomal recruitment of LAMP-1 correlated with higher LPG levels, decreased phagosomal acidification correlated with higher GP63 levels. Finally, we observed that the ability to infect and replicate within host cells did not fully correlate with the inhibition of phagosome maturation. Collectively, our results revealed a diversity of strain-specific phenotypes among L. braziliensis isolates, consistent with the high genetic diversity within Leishmania populations.


Sujet(s)
Glycosphingolipides/métabolisme , Interactions hôte-pathogène , Leishmania brasiliensis/immunologie , Leishmaniose cutanéomuqueuse/immunologie , Leishmaniose cutanéomuqueuse/parasitologie , Metalloendopeptidases/métabolisme , Phagosomes/métabolisme , Animaux , Cellules cultivées , Échappement immunitaire , Leishmania brasiliensis/croissance et développement , Protéine de membrane-1 associée au lysosome/antagonistes et inhibiteurs , Macrophages/immunologie , Macrophages/parasitologie , Souris de lignée C57BL , Biogenèse des organelles
14.
Biomolecules ; 9(8)2019 08 19.
Article de Anglais | MEDLINE | ID: mdl-31431000

RÉSUMÉ

Thimet oligopeptidase (THOP1) is thought to be involved in neuropeptide metabolism, antigen presentation, neurodegeneration, and cancer. Herein, the generation of THOP1 C57BL/6 knockout mice (THOP1-/-) is described showing that they are viable, have estrus cycle, fertility, and a number of puppies per litter similar to C57BL/6 wild type mice (WT). In specific brain regions, THOP1-/- exhibit altered mRNA expression of proteasome beta5, serotonin 5HT2a receptor and dopamine D2 receptor, but not of neurolysin (NLN). Peptidomic analysis identifies differences in intracellular peptide ratios between THOP1-/- and WT mice, which may affect normal cellular functioning. In an experimental model of multiple sclerosis THOP1-/- mice present worse clinical behavior scores compared to WT mice, corroborating its possible involvement in neurodegenerative diseases. THOP1-/- mice also exhibit better survival and improved behavior in a sepsis model, but also a greater peripheral pain sensitivity measured in the hot plate test after bradykinin administration in the paw. THOP1-/- mice show depressive-like behavior, as well as attention and memory retention deficits. Altogether, these results reveal a role of THOP1 on specific behaviors, immune-stimulated neurodegeneration, and infection-induced inflammation.


Sujet(s)
Metalloendopeptidases/métabolisme , Animaux , Comportement animal , Femelle , Mâle , Metalloendopeptidases/déficit , Metalloendopeptidases/génétique , Souris , Souris de lignée C57BL , Souris knockout , Phénotype
15.
Inflamm Res ; 68(10): 845-855, 2019 Oct.
Article de Anglais | MEDLINE | ID: mdl-31218444

RÉSUMÉ

INTRODUCTION: Carboxypeptidase M (CPM) is a glycosylphosphatidylinositol anchored enzyme that plays an important role in the kallikrein-kinin system (KKS). CPM catalytic domain hydrolyzes Arg from C-terminal peptides (i.e., bradykinin and kallidin), generating des-Arg-kinins, the agonists of B1 receptor (B1R). It is known that CPM and kinin B1R are co-localized in the plasma membrane microdomains, where they interact with each other, facilitating receptor signaling. AIMS: We hypothesized here that this CPM-B1R interaction could also affect the activity of the enzyme. METHODS: Thus, in this work, we evaluated the impact of B1R presence or absence on CPM activity and expression, using primary culture of microvascular endothelial cells from wild-type, kinin B1R knockout mice (B 1 -/- ), and transgenic rats overexpressing B1 receptor exclusively in the endothelium. In addition, HEK293T cells, as wells as B 1 -/- primary culture of endothelial cells, both transfected with B1R, were also used. RESULTS: CPM expression and activity were downregulated in cells of knockout mice compared to control and this reduction was rescued after B1R transfection. Cells overexpressing B1R presented higher levels of CPM mRNA, protein, and activity. This profile was reverted by pre-incubation with the B1R antagonist, R715, in highly expressing receptor cells. CONCLUSIONS: Our data show that kinin B1R positively modulates both CPM expression and activity, suggesting that CPM-B1R interaction in membrane microdomains might affect enzyme activity, beyond interfering in receptors signaling. This work highlights the interactions among different components of KKS and contributes to a better understanding of its patho-physiological role.


Sujet(s)
Cellules endothéliales/métabolisme , Metalloendopeptidases/métabolisme , Récepteur de la bradykinine de type B1/métabolisme , Animaux , Cellules cultivées , Protéines liées au GPI/génétique , Protéines liées au GPI/métabolisme , Humains , Poumon/cytologie , Metalloendopeptidases/génétique , Souris de lignée C57BL , Souris knockout , Rat Sprague-Dawley , Rats transgéniques , Récepteur de la bradykinine de type B1/génétique
16.
PLoS One ; 14(2): e0211643, 2019.
Article de Anglais | MEDLINE | ID: mdl-30716140

RÉSUMÉ

The aim of this study was to compare the treatment effects of laser photobiomodulation (LPBM) therapy and aerobic exercise on the biomechanical properties, tissue morphology and the expression of tendon matrix molecules during early remodeling of Achilles tendon (AT) injury in diabetic rats. Animals were randomly assigned to five groups: injured non diabetic (I, n = 15), injured diabetic (ID, n = 15), injured diabetic plus LPBM (IDL, n = 16), injured diabetic plus aerobic exercise (IDE, n = 16) and injured diabetic plus aerobic exercise and LPBM (IDEAL, n = 17). Type 1 diabetes was induced via a single intravenous injection of Streptozotocin at a dose of 40 mg/kg. A partial tenotomy was performed in the right AT. LPBM was performed with an indium-gallium-aluminum-phosphide 660 nm 10 mW laser device (spot size 0.04 cm2, power density 250 mW/cm2, irradiation duration 16 s, energy 0.16 J, energy density 4 J/cm2) on alternate days for a total of 9 sessions over 3 weeks (total energy 1.44 J), using a stationary contact technique to a single point over the dorsal aspect of the AT. Moderate aerobic exercise was performed on a motorized treadmill (velocity 9 m/min for 60 minutes). At 3 weeks post-injury, biomechanical analyzes as well as assessment of fibroblast number and orientation were performed. Collagen 1 (Col1) and 3 (Col3) and matrix metalloproteinases (MMPs) -3 and 13 protein distributions were studied by immunohistochemistry; while Col1 and Col3 and MMP-2 and 9 gene expression were assessed by quantitative RT-PCR (qRT-PCR). IDEAL exhibited significant increases in several biomechanical parameters in comparison to the other groups. Moreover, IDEAL presented stronger Col1 immunoreactivity when compared to ID, and weaker Col3 immunoreactivity than IDE. Both IDL and IDEAL demonstrated weaker expression of MMP-3 in comparison to I, while IDL presented no expression of MMP-13 when compared to ID. ID, IDL and IDE showed an increased number of fibroblasts in comparison to I, while IDEAL decreased the number of these cells in comparison to ID and IDE. IDL and IDEAL groups exhibited decreased angular dispersion among the fibroblasts when compared to I. The gene expression results showed that IDE demonstrated a downregulation in Col1 mRNA expression in comparison to I and ID. IDEAL demonstrated upregulation of Col1 mRNA expression when compared to IDL or IDE alone and increased MMP-2 expression when compared to IDL and IDE. MMP-9 expression was upregulated in IDEAL when compared to I, IDL and IDE. Our results suggest a beneficial interaction of combining both treatment strategies i.e., aerobic exercise and LPBM, on the biomechanical properties, tissue morphology and the expression of matrix molecules in diabetic tendons.


Sujet(s)
Tendon calcanéen/physiopathologie , Diabète expérimental/physiopathologie , Diabète de type 1/physiopathologie , Traumatismes des tendons/thérapie , Tendon calcanéen/métabolisme , Animaux , Collagène de type I/métabolisme , Collagène de type III/métabolisme , Diabète expérimental/induit chimiquement , Diabète expérimental/étiologie , Diabète expérimental/métabolisme , Diabète de type 1/induit chimiquement , Diabète de type 1/complications , Diabète de type 1/métabolisme , Fibroblastes/métabolisme , Photothérapie de faible intensité/méthodes , Mâle , Metalloendopeptidases/métabolisme , ARN messager/métabolisme , Rats , Rat Wistar , Streptozocine/pharmacologie , Traumatismes des tendons/étiologie , Traumatismes des tendons/métabolisme , Traumatismes des tendons/physiopathologie , Régulation positive/physiologie , Cicatrisation de plaie/physiologie
17.
Aging (Albany NY) ; 10(12): 3881-3896, 2018 12 10.
Article de Anglais | MEDLINE | ID: mdl-30530916

RÉSUMÉ

Idiopathic pulmonary fibrosis is a devastating aging-associated disease of unknown etiology. Despite that aging is a major risk factor, the mechanisms linking aging with this disease are uncertain, and experimental models to explore them in lung fibrosis are scanty. We examined the fibrotic response to bleomycin-induced lung injury in Zmpste24-deficient mice, which exhibit nuclear lamina defects developing accelerated aging. We found that young WT and Zmpste24(-/-) mice developed a similar fibrotic response to bleomycin. Unexpectedly, while old WT mice developed severe lung fibrosis, accelerated aged Zmpste24-/- mice were protected showing scant lung damage. To investigate possible mechanisms associated with this resistance to fibrosis, we compared the transcriptome signature of the lungs and found that Zmpste24(-/-) mice showed downregulation of several core and associated matrisome genes compared with WT mice. Interestingly, some microRNAs that target extracellular matrix molecules such as miR23a, miR27a, miR29a, miR29b-1, miR145a, and miR491 were dysregulated resulting in downregulation of profibrotic pathways such as TGF-ß/SMAD3/NF-κB and Wnt3a/ß-catenin signaling axis. These results indicate that the absence of Zmpste24 in aging mice results in impaired lung fibrotic response after injury, which is likely associated to the dysregulation of fibrosis-related miRNAs.


Sujet(s)
Vieillissement/génétique , Bléomycine/toxicité , Prédisposition génétique à une maladie , Protéines membranaires/métabolisme , Metalloendopeptidases/métabolisme , Fibrose pulmonaire/induit chimiquement , Animaux , Antibiotiques antinéoplasiques/toxicité , Protéines membranaires/génétique , Metalloendopeptidases/génétique , Souris , Souris de lignée C57BL , Souris knockout , microARN/génétique , microARN/métabolisme , Fibrose pulmonaire/génétique
18.
Biochimie ; 151: 73-84, 2018 Aug.
Article de Anglais | MEDLINE | ID: mdl-29864507

RÉSUMÉ

Cyclooxygenase-2 (COX-2) is an enzyme responsible of prostaglandins production, such as prostaglandin E2 (PGE2), an immune response modulator that regulates the immune system to inhibit Th1 and to promote Th2 cytokines production. Many parasites modulate their host immune response through PGE2 effects; however, in parasites, only one protein with COX activity has been described, the α-actinin of Entamoeba histolytica. Prostanoids production has been reported in some species of Leishmania but not the enzymes responsible of their production. To identify the protein responsible for COX activity in Leishmania mexicana, we examined total extracts of promastigotes and samples with COX activity were subjected to ion exchange column purification and precipitation with ammonium sulphate; fractions with activity were analyzed by SDS-PAGE and Western blot using an anti-mouse COX-2 polyclonal antibody. Results showed that in those samples with enzymatic activity, the anti-mouse COX-2 polyclonal antibody recognized a protein with an approximate molecular weight of 66 KDa. Bands recognized by the antibody were subjected to mass spectrometry analysis and the results showed that several peptides from the bands purified by two different methods, and that were recognized by the anti-mouse COX-2 polyclonal antibody corresponded to the Leishmania mexicana gp63 surface protease. L. mexicana gp63 was purified by a Concanavalin A (Con-A) affinity column and subjected to immunoprecipitation with a commercial anti-Leishmania gp63 polyclonal antibody; the immunoprecipitated sample was analyzed for COX activity showing that the anti-gp63 antibody did immunoprecipitate the COX activity. The presence of COX activity was further confirmed in amastigotes extracts of L. mexicana. Moreover, a recombinant gp63 protein was produced and its COX activity tested, confirming that gp63 is the molecule responsible for COX activity.


Sujet(s)
Leishmania mexicana/enzymologie , Metalloendopeptidases/métabolisme , Prostaglandin-endoperoxide synthases/métabolisme , Séquence d'acides aminés , Animaux , Technique de Western , Lignée cellulaire , Chromatographie d'affinité , Chromatographie sur DEAE-cellulose , Dinoprostone/métabolisme , Électrophorèse sur gel de polyacrylamide , Femelle , Humains , Immunoprécipitation , Spectrométrie de masse , Metalloendopeptidases/composition chimique , Metalloendopeptidases/isolement et purification , Souris de lignée BALB C , Prostaglandin-endoperoxide synthases/composition chimique , Prostaglandin-endoperoxide synthases/isolement et purification , Similitude de séquences d'acides aminés
19.
Parasitology ; 145(12): 1499-1509, 2018 10.
Article de Anglais | MEDLINE | ID: mdl-29530102

RÉSUMÉ

This is a systematic review on the role of metalloproteases in the pathogenicity of the American tegumentary leishmaniasis (ATL) caused by New World Leishmania species. The review followed the PRISMA method, searching for articles in PubMed, EMBASE, LILACS and ISI Web of Science, by employing the following terms: 'leishmaniasis', 'cutaneous leishmaniasis', 'mucocutaneous leishmaniasis', 'diffuse cutaneous leishmaniasis', 'Leishmania' and 'metalloproteases'. GP63 of New World Leishmania species is a parasite metalloproteases involved in the degradation and cleavage of many biological molecules as kappa-B nuclear factor, fibronectin, tyrosine phosphatases. GP63 is capable of inhibiting the activity of the complement system and reduces the host's immune functions, allowing the survival of the parasite and its dissemination. High serological/tissue levels of host matrix metalloproteases (MMP)-9 have been associated with tissue damage during the infection, while high transcriptional levels of MMP-2 related with a satisfactory response to treatment. Host MMPs serological and tissue levels have been investigated using Western Blot, zymography, and Real Time polymerase chain reaction. GP63 detection characterizes species and virulence in promastigotes isolated from lesions samples using techniques mentioned previously. The monitoring of host MMPs levels and GP63 in Leishmania isolated from host samples could be used on the laboratory routine to predict the prognostic and treatment efficacy of ATL.


Sujet(s)
Leishmania/enzymologie , Leishmaniose cutanée/enzymologie , Matrix metalloproteinase 2/métabolisme , Matrix metalloproteinase 9/métabolisme , Metalloendopeptidases/métabolisme , Metalloproteases/métabolisme , Humains , Leishmania/immunologie , Leishmania/pathogénicité , Leishmaniose cutanée/diagnostic , Leishmaniose cutanée/parasitologie , Pronostic , Virulence
20.
APMIS ; 126(3): 177-185, 2018 Mar.
Article de Anglais | MEDLINE | ID: mdl-29399876

RÉSUMÉ

Staphylococci produce a large number of extracellular proteases, some of which are considered as potential virulence factors. Staphylococcus epidermidis is a causative agent of nosocomial infections in medical devices by the formation of biofilms. It has been proposed that proteases contribute to the different stages of biofilm formation. S. epidermidis secretes a small number of extracellular proteases, such as serine protease Esp, cysteine protease EcpA, and metalloprotease SepA that have a relatively low substrate specificity. Recent findings indicate a significant contribution of extracellular proteases in biofilm formation through the proteolytic inactivation of adhesion molecules. The objective of this work is to provide an overview of the current knowledge of S. epidermidis' extracellular proteases during pathogenicity, especially in the different stages of biofilm formation.


Sujet(s)
Protéines bactériennes/métabolisme , Biofilms/croissance et développement , Cysteine proteases/métabolisme , Metalloendopeptidases/métabolisme , Protéases à sérine/métabolisme , Staphylococcus epidermidis/enzymologie , Molécules d'adhérence cellulaire/métabolisme , Infection croisée/microbiologie , Infection croisée/anatomopathologie , Humains , Infections à staphylocoques/microbiologie , Infections à staphylocoques/anatomopathologie , Staphylococcus epidermidis/métabolisme , Staphylococcus epidermidis/pathogénicité , Facteurs de virulence/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE